Bringing you live news and features since 2006 

Biotech and pharma ETF launch from iShares

RELATED TOPICS​

iShares has launch a new ETF offering access to biotechnology and pharmaceutical companies from the US. The ETF is traded on Xetra and Börse Frankfurt.

The firm writes that the iShares NASDAQ US Biotechnology UCITS ETF enables investors to participate in the performance of biotechnology and pharmaceutical companies from the US. The index components must be listed on NASDAQ and meet set admission criteria on market capitalisation and liquidity. The maximum weighting of an index component is eight percent. In addition, a maximum of five index components are permitted to reach this limit.

Latest News

21Shares AG has announced that the firm has added staking to the 21Shares Cosmos ETP (ATOM) and the 21Shares Avalanche..
EFAMA has published its latest Monthly Statistical Release for May 2024...
Solactive writes that it has expanded its collaboration with Kiwoom Asset Management by providing the underlying indices to the KIWOOM..
MSCI has announced the launch of MSCI Private Capital Indexes, writing that with growing investor interest in private markets, high..

Related Articles

Scott Kefer, VictoryEx Capital Holdings
Bailey McCann writes that active ETFs are capturing investor interest, according to the latest data from Morningstar, which finds that...
Chris Lo, Columbia Threadneedle
In a recent insight on India by Columbia Threadneedle Investments, the firm reports that the country’s economic reforms, which aim...
With an election on the horizon in the United States a group of ETFs is poised to capture investments on...
Robot worker
Qraft Technologies, based in South Korea, specialises in the use of AI in security selection and portfolio construction....
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by